Targeting T cells to hit B cells: Successful treatment of cutaneous plasmacytosis with topical pimecrolimus

Dermatology

Volumn 213, Issue 2, 2006, Pages 163-165

  Hafner, Christian ^a   Hohenleutner, Ulrich ^a   Babilas, Philipp ^a   Landthaler, Michael ^a   Vogt, Thomas ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Calcineurin; Cutaneous plasmacytosis; Pimecrolimus; Systemic plasmacytosis

Indexed keywords

IMMUNOGLOBULIN LIGHT CHAIN; PIMECROLIMUS;

AGED; ARTICLE; B LYMPHOCYTE; BONE MARROW; CASE REPORT; CLINICAL FEATURE; DRUG EFFECT; FACE; FEMALE; HUMAN; HYPOGAMMAGLOBULINEMIA; PLASMACYTOSIS; PRIORITY JOURNAL; T LYMPHOCYTE;

AGED; B-LYMPHOCYTES; BIOPSY; CALCINEURIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; PLASMACYTOMA; SKIN NEOPLASMS; T-LYMPHOCYTES; TACROLIMUS;

EID: 33747074066     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093860     Document Type: Article

References (17)

1. Shimizu S, Tanaka M, Shimizu H, Hanyaku H: Is cutaneous plasmacytosis a distinct clinical entity? J Am Acad Dermatol 1997;36:876-880.
2. Lopez-Estebaranz JL, Rodriguez-Peralto JL, Ortiz Romero PL, Vanaclocha F, Iglesias Diez L: Cutaneous plasmacytosis: report of a case in a white man. J Am Acad Dermatol 1994;31:897-900.
3. Tada Y, Komine M, Suzuki S, et al: Plasmacytosis: systemic or cutaneous, are they distinct? Acta Derm Venereol 2000;80:233-235.
4. Arico M, Bongiorno MR: Primary cutaneous plasmacytosis in a child: is this a new entity? J Eur Acad Dermatol Venereol 2002;16:164-167.
5. Carey WP, Rico MJ, Nierodzik M, Sidhu G: Systemic plasmacytosis with cutaneous manifestations in a white man: successful therapy with cyclophosphamide/prednisone. J Am Acad Dermatol 1998;38:629-631.
6. Cerottini JP, Guillod J, Vion B, Panizzon RG: Cutaneous plasmacytosis: an unusual presentation sharing features with POEMS syndrome? Dermatology 2001;202:49-51.
7. Uhara H, Saida T, Ikegawa S, et al: Primary cutaneous plasmacytosis: report of three cases and review of the literature. Dermatology 1994;189:251-255.
8. Nitta Y: Case of malignant lymphoma associated with primary systemic plasmacytosis with polyclonal hypergammaglobulinemia. Am J Dermatopathol 1997;19:289-293.
9. Lee DW, Choi SW, Park JW, Cho BK: Systemic plasmacytosis: a case which improved with melphalan. J Dermatol 1995;22:205-209.
10. Kaneda M, Kuroda K, Fujita M, Shinkai H: Successful treatment with topical PUVA of nodular cutaneous plasmacytosis associated with alopecia of the scalp. Clin Exp Dermatol 1996;21:360-364.
11. Yamamoto T, Katayama I, Nishioka K: Increased plasma interleukin-6 in cutaneous plasmacytoma: the effect of intralesional steroid therapy. Br J Dermatol 1997;137:631-636.
12. Miura H, Itami S, Yoshikawa K: Treatment of facial lesion of cutaneous plasmacytosis with tacrolimus ointment. J Am Acad Dermatol 2003;49:1195-1196.
13. Hultsch T, Kapp A, Spergel J: Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis. Dermatology 2005;211:174-187.
14. Gupta AK, Chow M: Pimecrolimus: a review. J Eur Acad Dermatol Venereol 2003;17:493-503.
15. Mayoral FA, Gonzalez C, Shah NS, Arciniegas C: Repigmentation of vitiligo with pimecrolimus cream: a case report. Dermatology 2003;207:322-323.
16. Lubbe J, Stucky L, Saurat JH: Rosaceiform dermatitis with follicular Demodex after treatment of facial atopic dermatitis with 1% pimecrolimus cream. Dermatology 2003;207:204-205.
17. Higashigawa M, Komada Y, Shimono Y, et al: FK506 inhibits anti-IgM antibody-induced apoptosis and 17 kD endonuclease activity in the human B-cell line, MBC-1, established from Burkitt's lymphoma. Br J Haematol 1997;99:908-913.